Publications by authors named "Larry D Bratton"

Claim this Profile
S
Synthesis of novel 6-azacytidine prodrugs as potent influenza A inhibitors.
Omar Moukha-Chafiq, Larry D Bratton, Shuklendu D Karyakarte, Kathy Keith, Yohanka Martinez-Gzegozewska

Bioorg Med Chem Lett· February 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a novel non-toxic analog of clofarabine for the treatment of triple-negative breast cancer.
Omar Moukha-Chafiq, Rebecca Boohaker, Larry D Bratton, Marina Fosso Yatchang, Anish K Vadukoot

Bioorg Med Chem Lett· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a series of 2-(1H-pyrazol-1-yl)pyridines as ALK5 inhibitors with potential utility in the prevention of dermal scarring.
Mark L Boys, Feng Bian, James B Kramer, Christopher L Chio, Xiao-Dan Ren, Larry D Bratton

Bioorg Med Chem Lett· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thermodynamic and structure guided design of statin based inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase.
Ronald W Sarver, Elizabeth Bills, Gary Bolton, Larry D Bratton, Nicole L Caspers

J Med Chem· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of pyrrole-based hepatoselective ligands as potent inhibitors of HMG-CoA reductase.
Larry D Bratton, Bruce Auerbach, Chulho Choi, Lisa Dillon, Jeffrey C Hanselman

Bioorg Med Chem· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and synthesis of hepatoselective, pyrrole-based HMG-CoA reductase inhibitors.
Jeffrey A Pfefferkorn, Yuntao Song, Kuai-Lin Sun, Steven R Miller, Bharat K Trivedi, Larry D Bratton

Bioorg Med Chem Lett· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of highly potent and selective benzyloxybenzyl-based peroxisome proliferator-activator receptor (PPAR) delta agonists.
Larry D Bratton, Gary F Filzen, Andrew Geyer, Jennifer K Hoffman, Gina Lu

Bioorg Med Chem Lett· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis